塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/06/15 | 6,670 | 6,683 | 6,476 | 6,493 | -241 | -3.6% | 1,666,300 |
2022/06/14 | 6,742 | 6,766 | 6,674 | 6,734 | -81 | -1.2% | 1,092,800 |
2022/06/13 | 6,865 | 6,930 | 6,782 | 6,815 | -187 | -2.7% | 1,140,000 |
2022/06/10 | 7,114 | 7,114 | 6,966 | 7,002 | -147 | -2.1% | 1,160,400 |
2022/06/09 | 7,119 | 7,278 | 7,104 | 7,149 | +20 | +0.3% | 1,413,800 |
2022/06/08 | 6,951 | 7,129 | 6,925 | 7,129 | +197 | +2.8% | 1,528,000 |
2022/06/07 | 6,877 | 6,944 | 6,826 | 6,932 | +75 | +1.1% | 1,094,100 |
2022/06/06 | 6,801 | 6,878 | 6,784 | 6,857 | +74 | +1.1% | 977,200 |
2022/06/03 | 6,748 | 6,818 | 6,708 | 6,783 | +116 | +1.7% | 1,176,200 |
2022/06/02 | 6,789 | 6,790 | 6,656 | 6,667 | -161 | -2.4% | 1,217,800 |
2022/06/01 | 6,830 | 6,889 | 6,793 | 6,828 | -49 | -0.7% | 1,020,400 |
2022/05/31 | 6,866 | 7,011 | 6,808 | 6,877 | +61 | +0.9% | 3,663,000 |
2022/05/30 | 6,791 | 6,828 | 6,745 | 6,816 | +80 | +1.2% | 1,403,400 |
2022/05/27 | 6,820 | 6,824 | 6,626 | 6,736 | -38 | -0.6% | 1,908,900 |
2022/05/26 | 6,777 | 6,854 | 6,767 | 6,774 | -14 | -0.2% | 1,059,900 |
2022/05/25 | 6,882 | 6,927 | 6,777 | 6,788 | -106 | -1.5% | 1,227,600 |
2022/05/24 | 6,941 | 6,966 | 6,881 | 6,894 | -73 | -1% | 1,155,700 |
2022/05/23 | 6,831 | 6,974 | 6,821 | 6,967 | +191 | +2.8% | 1,452,100 |
2022/05/20 | 6,764 | 6,820 | 6,702 | 6,776 | +28 | +0.4% | 1,708,800 |
2022/05/19 | 6,755 | 6,771 | 6,646 | 6,748 | -184 | -2.7% | 1,900,700 |
2022/05/18 | 6,980 | 6,994 | 6,907 | 6,932 | -94 | -1.3% | 1,351,100 |
2022/05/17 | 6,939 | 7,079 | 6,904 | 7,026 | +179 | +2.6% | 1,676,100 |
2022/05/16 | 6,988 | 6,988 | 6,808 | 6,847 | +17 | +0.2% | 1,400,600 |
2022/05/13 | 6,850 | 6,865 | 6,696 | 6,830 | +77 | +1.1% | 2,166,100 |
2022/05/12 | 6,998 | 7,020 | 6,738 | 6,753 | -212 | -3% | 2,137,800 |
2022/05/11 | 7,009 | 7,139 | 6,776 | 6,965 | -124 | -1.7% | 2,209,300 |
2022/05/10 | 7,051 | 7,118 | 6,964 | 7,089 | -21 | -0.3% | 1,233,300 |
2022/05/09 | 7,280 | 7,303 | 7,077 | 7,110 | -222 | -3% | 1,372,500 |
2022/05/06 | 7,185 | 7,337 | 7,170 | 7,332 | +104 | +1.4% | 1,348,200 |
2022/05/02 | 7,384 | 7,384 | 7,221 | 7,228 | -43 | -0.6% | 1,418,000 |
2022/04/28 | 7,219 | 7,299 | 7,172 | 7,271 | +62 | +0.9% | 1,700,600 |
2022/04/27 | 7,029 | 7,210 | 7,000 | 7,209 | +123 | +1.7% | 1,952,000 |
2022/04/26 | 7,046 | 7,129 | 7,007 | 7,086 | +140 | +2% | 1,853,000 |
2022/04/25 | 6,977 | 7,025 | 6,915 | 6,946 | -9 | -0.1% | 1,560,400 |
2022/04/22 | 7,032 | 7,069 | 6,867 | 6,955 | +73 | +1.1% | 2,184,000 |
2022/04/21 | 6,900 | 6,924 | 6,796 | 6,882 | +2 | ±0% | 1,371,500 |
2022/04/20 | 6,806 | 6,955 | 6,805 | 6,880 | +75 | +1.1% | 1,722,800 |
2022/04/19 | 6,737 | 6,836 | 6,700 | 6,805 | +19 | +0.3% | 1,420,800 |
2022/04/18 | 6,710 | 6,810 | 6,688 | 6,786 | -24 | -0.4% | 1,384,000 |
2022/04/15 | 6,927 | 6,992 | 6,782 | 6,810 | -166 | -2.4% | 2,416,900 |
2022/04/14 | 6,780 | 7,014 | 6,722 | 6,976 | +365 | +5.5% | 5,926,000 |
2022/04/13 | 6,500 | 6,680 | 6,252 | 6,611 | -829 | -11.1% | 11,280,000 |
2022/04/12 | 7,455 | 7,497 | 7,372 | 7,440 | -103 | -1.4% | 1,042,600 |
2022/04/11 | 7,545 | 7,585 | 7,491 | 7,543 | -1 | ±0% | 981,700 |
2022/04/08 | 7,637 | 7,640 | 7,441 | 7,544 | -25 | -0.3% | 1,661,700 |
2022/04/07 | 7,350 | 7,579 | 7,310 | 7,569 | +173 | +2.3% | 1,399,900 |
2022/04/06 | 7,435 | 7,512 | 7,378 | 7,396 | -61 | -0.8% | 1,362,400 |
2022/04/05 | 7,560 | 7,573 | 7,360 | 7,457 | -66 | -0.9% | 1,194,900 |
2022/04/04 | 7,293 | 7,529 | 7,245 | 7,523 | +282 | +3.9% | 1,484,100 |
2022/04/01 | 7,430 | 7,480 | 7,042 | 7,241 | -289 | -3.8% | 2,948,400 |
601~
650
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 212,200円 | +5.7% | +3.9% | 2.70% | 10.56倍 | 1.40倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 893,800円 | +14.4% | +120.8% | 1.34% | 20.06倍 | 1.84倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 158,300円 | +12.2% | +180.3% | 4.67% | 56.68倍 | 1.85倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 464,200円 | +1.7% | -2.9% | 3.45% | 30.46倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,400円 | +11.3% | -5.4% | 2.30% | 19.43倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム